866-997-4948(US-Canada Toll Free)

Advanced Cancer Therapeutics - Product Pipeline Review - 2013

Published By :

Global Markets Direct

Published Date : Jul 2013

Category :

Cancer

No. of Pages : 25 Pages


Global Markets Directs pharmaceuticals report, Advanced Cancer Therapeutics Product Pipeline Review 2013 provides data on the Advanced Cancer Therapeuticss research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. 

This report is built using data and information sourced from Global Markets Directs proprietary databases, Advanced Cancer Therapeuticss corporate website, SEC filings, investor presentations and featured press releases, both from Advanced Cancer Therapeutics and industry-specific third party sources, put together by Global Markets Directs team. 

Scope

  • Advanced Cancer Therapeutics Brief Advanced Cancer Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Advanced Cancer Therapeutics human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Advanced Cancer Therapeutics with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones. 
  • Recent updates of the Advanced Cancer Therapeuticss pipeline in the last quarter. 
  • Key discontinued and dormant projects. 
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Advanced Cancer Therapeuticss strategic position with total access to detailed information on its product pipeline. 
  • Assess the growth potential of Advanced Cancer Therapeutics in its therapy areas of focus. 
  • Identify new drug targets and therapeutic classes in the Advanced Cancer Therapeuticss R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. 
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. 
  • Exploit collaboration and partnership opportunities with Advanced Cancer Therapeutics. 
  • Avoid Intellectual Property Rights related issues. 
  • Explore the dormant and discontinued projects of Advanced Cancer Therapeutics and identify potential opportunities in those areas.
Table of Contents

Table of Contents 2

List of Tables 3
List of Figures 3
Advanced Cancer Therapeutics Snapshot 4
Advanced Cancer Therapeutics Overview 4
Key Information 4
Key Facts 4
Advanced Cancer Therapeutics Research and Development Overview 5
Key Therapeutic Areas 5
Advanced Cancer Therapeutics Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products Monotherapy 8
Advanced Cancer Therapeutics Pipeline Products Glance 9
Advanced Cancer Therapeutics Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Advanced Cancer Therapeutics Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Advanced Cancer Therapeutics Drug Profiles 12
3-PO 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
ACT-GRO-777 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
CK-37 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
HPV Vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PU-27 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Advanced Cancer Therapeutics Pipeline Analysis 17
Advanced Cancer Therapeutics Pipeline Products by Therapeutic Class 17
Advanced Cancer Therapeutics Pipeline Products By Target 18
Advanced Cancer Therapeutics Pipeline Products by Route of Administration 19
Advanced Cancer Therapeutics Pipeline Products By Mechanism of Action 20
Advanced Cancer Therapeutics Recent Pipeline Updates 21
Advanced Cancer Therapeutics - Dormant Projects 22
Advanced Cancer Therapeutics Locations And Subsidiaries 23
Head Office 23

Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Table


Advanced Cancer Therapeutics, Key Information 4
Advanced Cancer Therapeutics, Key Facts 4
Advanced Cancer Therapeutics Pipeline by Indication, 2013 6
Advanced Cancer Therapeutics Pipeline by Stage of Development, 2013 7
Advanced Cancer Therapeutics Monotherapy Products in Pipeline, 2013 8
Advanced Cancer Therapeutics Phase II, 2013 9
Advanced Cancer Therapeutics Phase I, 2013 10
Advanced Cancer Therapeutics Preclinical, 2013 11
Advanced Cancer Therapeutics Pipeline By Therapeutic Class, 2013 17
Advanced Cancer Therapeutics - Pipeline By Target, 2013 18
Advanced Cancer Therapeutics Pipeline By Route of Administration, 2013 19
Advanced Cancer Therapeutics Pipeline Products By Mechanism of Action, 2013 20
Advanced Cancer Therapeutics Recent Pipeline Updates, 2013 21
Advanced Cancer Therapeutics - Dormant Developmental Projects,2013 22

List of Chart


Advanced Cancer Therapeutics Pipeline by Indication, 2013 6
Advanced Cancer Therapeutics Pipeline by Stage of Development, 2013 7
Advanced Cancer Therapeutics Monotherapy Products in Pipeline, 2013 8
Advanced Cancer Therapeutics Pipeline By Therapeutic Class, 2013 17
Advanced Cancer Therapeutics Pipeline By Route of Administration, 2013 19
Advanced Cancer Therapeutics - Pipeline Products By Mechanism of Action, 2013 20

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *